Core Laboratories (CLB) Receivables - Net (2022 - 2026)

Core Laboratories' Receivables - Net history runs 5 years deep, the most recent figure standing at $108.3 million for Q1 2026.

• On a quarterly basis, Receivables - Net fell 7.48% year-over-year to $108.3 million in Q1 2026; TTM through Mar 2026 was $108.3 million, a 7.48% decrease from a year earlier, with the FY2025 full-year figure at $113.5 million, up 1.58% from the prior year.
• Receivables - Net slipped to $108.3 million in Q1 2026 per CLB's latest filing, from $113.5 million in the prior quarter.
• Across five years, Receivables - Net topped out at $117.6 million in Q3 2024 and bottomed at $104.1 million in Q3 2023.
• The 5-year median for Receivables - Net is $111.8 million (2024), against an average of $111.6 million.
• Across the five-year window, Receivables - Net increased 13.01% in 2024 and declined 7.48% in 2026, its largest moves.
• Year by year, Receivables - Net stood at $106.9 million in 2022, then grew by 2.28% to $109.4 million in 2023, then climbed by 2.2% to $111.8 million in 2024, then grew by 1.58% to $113.5 million in 2025, then slipped by 4.63% to $108.3 million in 2026.
• Per Business Quant, the three latest CLB Receivables - Net figures stand at $108.3 million (Q1 2026), $113.5 million (Q4 2025), and $110.3 million (Q3 2025).